nodes	percent_of_prediction	percent_of_DWPC	metapath
Dapsone—NAT2—prostate cancer	0.13	0.289	CbGaD
Dapsone—CYP2C18—prostate cancer	0.0827	0.184	CbGaD
Dapsone—MPO—prostate cancer	0.0616	0.137	CbGaD
Dapsone—CYP3A5—prostate cancer	0.0545	0.121	CbGaD
Dapsone—CYP2E1—prostate cancer	0.0375	0.0832	CbGaD
Dapsone—CYP2C19—prostate cancer	0.0371	0.0824	CbGaD
Dapsone—CYP3A4—prostate cancer	0.0236	0.0524	CbGaD
Dapsone—PTGS2—prostate cancer	0.0231	0.0513	CbGaD
Dapsone—CYP2C8—Nilutamide—prostate cancer	0.0183	0.0514	CbGbCtD
Dapsone—CYP3A5—Flutamide—prostate cancer	0.0158	0.0443	CbGbCtD
Dapsone—CYP2C19—Nilutamide—prostate cancer	0.0153	0.0432	CbGbCtD
Dapsone—CYP2C19—Bicalutamide—prostate cancer	0.0153	0.0432	CbGbCtD
Dapsone—CYP2C8—Abiraterone—prostate cancer	0.0152	0.0426	CbGbCtD
Dapsone—CYP2E1—Estrone—prostate cancer	0.0147	0.0413	CbGbCtD
Dapsone—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.0141	0.0397	CbGbCtD
Dapsone—CYP2C9—Nilutamide—prostate cancer	0.0128	0.0359	CbGbCtD
Dapsone—CYP2C9—Bicalutamide—prostate cancer	0.0128	0.0359	CbGbCtD
Dapsone—CYP2C19—Flutamide—prostate cancer	0.0127	0.0358	CbGbCtD
Dapsone—CYP3A5—Cabazitaxel—prostate cancer	0.0117	0.0328	CbGbCtD
Dapsone—CYP3A5—Estrone—prostate cancer	0.0114	0.0321	CbGbCtD
Dapsone—CYP2C8—Cabazitaxel—prostate cancer	0.0112	0.0315	CbGbCtD
Dapsone—CYP2C8—Ethinyl Estradiol—prostate cancer	0.00976	0.0275	CbGbCtD
Dapsone—CYP3A7—Estradiol—prostate cancer	0.00872	0.0245	CbGbCtD
Dapsone—CYP3A7-CYP3A51P—Estradiol—prostate cancer	0.00872	0.0245	CbGbCtD
Dapsone—CYP2E1—Mitoxantrone—prostate cancer	0.00872	0.0245	CbGbCtD
Dapsone—NAT2—urine—prostate cancer	0.00869	0.269	CbGeAlD
Dapsone—PTGS2—Etoposide—prostate cancer	0.00843	0.0237	CbGbCtD
Dapsone—CYP2C9—Estrone—prostate cancer	0.00764	0.0215	CbGbCtD
Dapsone—CYP3A4—Bicalutamide—prostate cancer	0.00742	0.0209	CbGbCtD
Dapsone—PTGS1—Etoposide—prostate cancer	0.00712	0.02	CbGbCtD
Dapsone—CYP3A4—Estramustine—prostate cancer	0.00689	0.0194	CbGbCtD
Dapsone—CYP3A5—Estradiol—prostate cancer	0.00654	0.0184	CbGbCtD
Dapsone—CYP2C8—Estradiol—prostate cancer	0.00629	0.0177	CbGbCtD
Dapsone—CYP3A4—Abiraterone—prostate cancer	0.00615	0.0173	CbGbCtD
Dapsone—CYP3A4—Flutamide—prostate cancer	0.00615	0.0173	CbGbCtD
Dapsone—CYP2C9—Capecitabine—prostate cancer	0.00579	0.0163	CbGbCtD
Dapsone—CYP2E1—Etoposide—prostate cancer	0.0055	0.0155	CbGbCtD
Dapsone—CYP2C19—Estradiol—prostate cancer	0.00528	0.0149	CbGbCtD
Dapsone—CYP3A7—Docetaxel—prostate cancer	0.00521	0.0147	CbGbCtD
Dapsone—CYP3A7-CYP3A51P—Docetaxel—prostate cancer	0.00521	0.0147	CbGbCtD
Dapsone—CYP3A4—Cabazitaxel—prostate cancer	0.00455	0.0128	CbGbCtD
Dapsone—CYP2C19—Prednisone—prostate cancer	0.00454	0.0128	CbGbCtD
Dapsone—CYP3A4—Estrone—prostate cancer	0.00444	0.0125	CbGbCtD
Dapsone—CYP2C9—Estradiol—prostate cancer	0.00439	0.0123	CbGbCtD
Dapsone—CYP3A5—Etoposide—prostate cancer	0.00427	0.012	CbGbCtD
Dapsone—CYP2C8—Etoposide—prostate cancer	0.00411	0.0116	CbGbCtD
Dapsone—CYP3A4—Ethinyl Estradiol—prostate cancer	0.00396	0.0111	CbGbCtD
Dapsone—FMO3—urine—prostate cancer	0.00394	0.122	CbGeAlD
Dapsone—CYP3A5—Docetaxel—prostate cancer	0.00391	0.011	CbGbCtD
Dapsone—CYP3A4—Conjugated Estrogens—prostate cancer	0.00291	0.00818	CbGbCtD
Dapsone—CYP3A4—Mitoxantrone—prostate cancer	0.00264	0.00743	CbGbCtD
Dapsone—CYP3A4—Estradiol—prostate cancer	0.00255	0.00718	CbGbCtD
Dapsone—CYP3A4—Prednisone—prostate cancer	0.00219	0.00617	CbGbCtD
Dapsone—NAT2—renal system—prostate cancer	0.00213	0.0657	CbGeAlD
Dapsone—CYP2C19—urine—prostate cancer	0.00174	0.0539	CbGeAlD
Dapsone—CYP3A4—Etoposide—prostate cancer	0.00167	0.00469	CbGbCtD
Dapsone—CYP3A4—Docetaxel—prostate cancer	0.00152	0.00429	CbGbCtD
Dapsone—FMO3—prostate gland—prostate cancer	0.00142	0.0438	CbGeAlD
Dapsone—CYP2C9—urine—prostate cancer	0.00135	0.0418	CbGeAlD
Dapsone—CYP2E1—urine—prostate cancer	0.00128	0.0396	CbGeAlD
Dapsone—CYP3A4—Doxorubicin—prostate cancer	0.00114	0.0032	CbGbCtD
Dapsone—CYP3A4—urine—prostate cancer	0.00103	0.0319	CbGeAlD
Dapsone—Sulfamethoxazole—NAT1—prostate cancer	0.000971	0.453	CrCbGaD
Dapsone—MPO—epithelium—prostate cancer	0.000686	0.0212	CbGeAlD
Dapsone—MPO—renal system—prostate cancer	0.000636	0.0197	CbGeAlD
Dapsone—FMO3—testis—prostate cancer	0.000624	0.0193	CbGeAlD
Dapsone—CYP3A5—prostate gland—prostate cancer	0.000493	0.0152	CbGeAlD
Dapsone—MPO—bone marrow—prostate cancer	0.000481	0.0149	CbGeAlD
Dapsone—CYP2E1—prostate gland—prostate cancer	0.00046	0.0142	CbGeAlD
Dapsone—FMO3—lymph node—prostate cancer	0.000452	0.014	CbGeAlD
Dapsone—PTGS1—prostate gland—prostate cancer	0.000443	0.0137	CbGeAlD
Dapsone—PTGS2—prostate gland—prostate cancer	0.000423	0.0131	CbGeAlD
Dapsone—Muscular weakness—Bicalutamide—prostate cancer	0.000412	0.00732	CcSEcCtD
Dapsone—MPO—testis—prostate cancer	0.000411	0.0127	CbGeAlD
Dapsone—Neuropathy peripheral—Cabazitaxel—prostate cancer	0.000411	0.00731	CcSEcCtD
Dapsone—Influenza—Bicalutamide—prostate cancer	0.000403	0.00718	CcSEcCtD
Dapsone—CYP2E1—seminal vesicle—prostate cancer	0.000389	0.012	CbGeAlD
Dapsone—Erythema—Flutamide—prostate cancer	0.000388	0.00689	CcSEcCtD
Dapsone—Proteinuria—Mitoxantrone—prostate cancer	0.000376	0.00669	CcSEcCtD
Dapsone—PTGS1—seminal vesicle—prostate cancer	0.000375	0.0116	CbGeAlD
Dapsone—CYP2C8—renal system—prostate cancer	0.000372	0.0115	CbGeAlD
Dapsone—Cough—Abiraterone—prostate cancer	0.000372	0.00661	CcSEcCtD
Dapsone—Protein urine present—Mitoxantrone—prostate cancer	0.000371	0.0066	CcSEcCtD
Dapsone—PTGS2—seminal vesicle—prostate cancer	0.000358	0.0111	CbGeAlD
Dapsone—Neuropathy peripheral—Bicalutamide—prostate cancer	0.000353	0.00627	CcSEcCtD
Dapsone—Tinnitus—Cabazitaxel—prostate cancer	0.000351	0.00624	CcSEcCtD
Dapsone—Erythema—Degarelix—prostate cancer	0.000348	0.00619	CcSEcCtD
Dapsone—Cough—Nilutamide—prostate cancer	0.00034	0.00604	CcSEcCtD
Dapsone—Skin exfoliation—Estradiol—prostate cancer	0.000339	0.00602	CcSEcCtD
Dapsone—Sinusitis—Bicalutamide—prostate cancer	0.000337	0.006	CcSEcCtD
Dapsone—CYP3A5—renal system—prostate cancer	0.000336	0.0104	CbGeAlD
Dapsone—Vision blurred—Degarelix—prostate cancer	0.000328	0.00583	CcSEcCtD
Dapsone—Erythema—Cabazitaxel—prostate cancer	0.000328	0.00583	CcSEcCtD
Dapsone—PTGS1—epithelium—prostate cancer	0.000325	0.0101	CbGeAlD
Dapsone—Insomnia—Estramustine—prostate cancer	0.000324	0.00576	CcSEcCtD
Dapsone—Pharyngitis—Bicalutamide—prostate cancer	0.00032	0.0057	CcSEcCtD
Dapsone—Psychotic disorder—Goserelin—prostate cancer	0.000317	0.00564	CcSEcCtD
Dapsone—Insomnia—Abiraterone—prostate cancer	0.000315	0.0056	CcSEcCtD
Dapsone—CYP2E1—renal system—prostate cancer	0.000313	0.00969	CbGeAlD
Dapsone—PTGS2—epithelium—prostate cancer	0.000311	0.00962	CbGeAlD
Dapsone—CYP2E1—urethra—prostate cancer	0.000308	0.00952	CbGeAlD
Dapsone—Sulfamethoxazole—NAT2—prostate cancer	0.000306	0.143	CrCbGaD
Dapsone—PTGS1—renal system—prostate cancer	0.000302	0.00934	CbGeAlD
Dapsone—MPO—lymph node—prostate cancer	0.000298	0.00922	CbGeAlD
Dapsone—Neuropathy peripheral—Ethinyl Estradiol—prostate cancer	0.000298	0.0053	CcSEcCtD
Dapsone—Vertigo—Cabazitaxel—prostate cancer	0.000294	0.00524	CcSEcCtD
Dapsone—PTGS2—renal system—prostate cancer	0.000288	0.00892	CbGeAlD
Dapsone—Insomnia—Nilutamide—prostate cancer	0.000287	0.00511	CcSEcCtD
Dapsone—Insomnia—Flutamide—prostate cancer	0.000286	0.00509	CcSEcCtD
Dapsone—Cough—Cabazitaxel—prostate cancer	0.000286	0.00509	CcSEcCtD
Dapsone—Sinusitis—Ethinyl Estradiol—prostate cancer	0.000285	0.00507	CcSEcCtD
Dapsone—PTGS2—urethra—prostate cancer	0.000283	0.00877	CbGeAlD
Dapsone—Influenza—Goserelin—prostate cancer	0.000281	0.00499	CcSEcCtD
Dapsone—Influenza—Conjugated Estrogens—prostate cancer	0.000278	0.00494	CcSEcCtD
Dapsone—Sulfathiazole—CYP19A1—prostate cancer	0.000277	0.129	CrCbGaD
Dapsone—Body temperature increased—Abiraterone—prostate cancer	0.000275	0.00489	CcSEcCtD
Dapsone—Pancreatitis—Conjugated Estrogens—prostate cancer	0.000273	0.00485	CcSEcCtD
Dapsone—Pharyngitis—Ethinyl Estradiol—prostate cancer	0.000271	0.00482	CcSEcCtD
Dapsone—Abdominal pain—Estrone—prostate cancer	0.00027	0.00481	CcSEcCtD
Dapsone—Skin exfoliation—Etoposide—prostate cancer	0.000262	0.00467	CcSEcCtD
Dapsone—Tachycardia—Cabazitaxel—prostate cancer	0.000261	0.00464	CcSEcCtD
Dapsone—Gastrointestinal pain—Nilutamide—prostate cancer	0.00026	0.00462	CcSEcCtD
Dapsone—Insomnia—Degarelix—prostate cancer	0.000257	0.00457	CcSEcCtD
Dapsone—Photosensitivity reaction—Goserelin—prostate cancer	0.000256	0.00456	CcSEcCtD
Dapsone—CYP3A4—renal system—prostate cancer	0.000252	0.0078	CbGeAlD
Dapsone—Proteinuria—Capecitabine—prostate cancer	0.000252	0.00448	CcSEcCtD
Dapsone—Body temperature increased—Nilutamide—prostate cancer	0.000251	0.00447	CcSEcCtD
Dapsone—Abdominal pain—Nilutamide—prostate cancer	0.000251	0.00447	CcSEcCtD
Dapsone—Protein urine present—Capecitabine—prostate cancer	0.000248	0.00441	CcSEcCtD
Dapsone—Cough—Bicalutamide—prostate cancer	0.000245	0.00436	CcSEcCtD
Dapsone—Gastrointestinal pain—Estradiol valerate/Dienogest—prostate cancer	0.000244	0.00434	CcSEcCtD
Dapsone—Neuropathy peripheral—Conjugated Estrogens—prostate cancer	0.000243	0.00432	CcSEcCtD
Dapsone—CYP2C8—testis—prostate cancer	0.000241	0.00744	CbGeAlD
Dapsone—Abdominal pain—Estradiol valerate/Dienogest—prostate cancer	0.000236	0.0042	CcSEcCtD
Dapsone—Sinusitis—Goserelin—prostate cancer	0.000235	0.00418	CcSEcCtD
Dapsone—Sinusitis—Conjugated Estrogens—prostate cancer	0.000233	0.00414	CcSEcCtD
Dapsone—Gastrointestinal pain—Degarelix—prostate cancer	0.000232	0.00413	CcSEcCtD
Dapsone—Nasopharyngitis—Estradiol—prostate cancer	0.00023	0.00409	CcSEcCtD
Dapsone—Vomiting—Estramustine—prostate cancer	0.000228	0.00405	CcSEcCtD
Dapsone—Abdominal pain—Degarelix—prostate cancer	0.000224	0.00399	CcSEcCtD
Dapsone—Body temperature increased—Degarelix—prostate cancer	0.000224	0.00399	CcSEcCtD
Dapsone—Headache—Estramustine—prostate cancer	0.000224	0.00399	CcSEcCtD
Dapsone—Pharyngitis—Goserelin—prostate cancer	0.000223	0.00397	CcSEcCtD
Dapsone—Influenza—Estradiol—prostate cancer	0.000222	0.00396	CcSEcCtD
Dapsone—Vomiting—Abiraterone—prostate cancer	0.000221	0.00393	CcSEcCtD
Dapsone—Pharyngitis—Conjugated Estrogens—prostate cancer	0.000221	0.00393	CcSEcCtD
Dapsone—Gastrointestinal pain—Cabazitaxel—prostate cancer	0.000219	0.00389	CcSEcCtD
Dapsone—PTGS2—bone marrow—prostate cancer	0.000218	0.00675	CbGeAlD
Dapsone—Pancreatitis—Estradiol—prostate cancer	0.000218	0.00388	CcSEcCtD
Dapsone—Skin exfoliation—Docetaxel—prostate cancer	0.000218	0.00388	CcSEcCtD
Dapsone—Vomiting—Estrone—prostate cancer	0.000218	0.00387	CcSEcCtD
Dapsone—Headache—Estrone—prostate cancer	0.000214	0.00381	CcSEcCtD
Dapsone—Nausea—Estramustine—prostate cancer	0.000213	0.00378	CcSEcCtD
Dapsone—Body temperature increased—Cabazitaxel—prostate cancer	0.000211	0.00376	CcSEcCtD
Dapsone—Abdominal pain—Cabazitaxel—prostate cancer	0.000211	0.00376	CcSEcCtD
Dapsone—Skin exfoliation—Capecitabine—prostate cancer	0.000211	0.00375	CcSEcCtD
Dapsone—Insomnia—Bicalutamide—prostate cancer	0.000207	0.00369	CcSEcCtD
Dapsone—Cough—Ethinyl Estradiol—prostate cancer	0.000207	0.00369	CcSEcCtD
Dapsone—Albuminuria—Epirubicin—prostate cancer	0.000206	0.00367	CcSEcCtD
Dapsone—Nausea—Estrone—prostate cancer	0.000203	0.00361	CcSEcCtD
Dapsone—Photosensitivity reaction—Estradiol—prostate cancer	0.000203	0.00361	CcSEcCtD
Dapsone—CYP2E1—testis—prostate cancer	0.000203	0.00626	CbGeAlD
Dapsone—Vomiting—Nilutamide—prostate cancer	0.000202	0.00359	CcSEcCtD
Dapsone—Vomiting—Flutamide—prostate cancer	0.000201	0.00358	CcSEcCtD
Dapsone—Headache—Nilutamide—prostate cancer	0.000199	0.00354	CcSEcCtD
Dapsone—Headache—Flutamide—prostate cancer	0.000198	0.00353	CcSEcCtD
Dapsone—Erythema—Goserelin—prostate cancer	0.000196	0.00348	CcSEcCtD
Dapsone—PTGS1—testis—prostate cancer	0.000195	0.00603	CbGeAlD
Dapsone—Neuropathy peripheral—Estradiol—prostate cancer	0.000194	0.00346	CcSEcCtD
Dapsone—Erythema—Conjugated Estrogens—prostate cancer	0.000194	0.00344	CcSEcCtD
Dapsone—Albuminuria—Doxorubicin—prostate cancer	0.000191	0.0034	CcSEcCtD
Dapsone—Vomiting—Estradiol valerate/Dienogest—prostate cancer	0.00019	0.00338	CcSEcCtD
Dapsone—Nausea—Nilutamide—prostate cancer	0.000189	0.00336	CcSEcCtD
Dapsone—Skin exfoliation—Prednisone—prostate cancer	0.000188	0.00334	CcSEcCtD
Dapsone—Nausea—Flutamide—prostate cancer	0.000188	0.00334	CcSEcCtD
Dapsone—Gastrointestinal pain—Bicalutamide—prostate cancer	0.000188	0.00334	CcSEcCtD
Dapsone—Headache—Estradiol valerate/Dienogest—prostate cancer	0.000187	0.00333	CcSEcCtD
Dapsone—Sinusitis—Estradiol—prostate cancer	0.000186	0.00331	CcSEcCtD
Dapsone—Vision blurred—Goserelin—prostate cancer	0.000184	0.00328	CcSEcCtD
Dapsone—Vision blurred—Conjugated Estrogens—prostate cancer	0.000183	0.00325	CcSEcCtD
Dapsone—Abdominal pain—Bicalutamide—prostate cancer	0.000181	0.00323	CcSEcCtD
Dapsone—Body temperature increased—Bicalutamide—prostate cancer	0.000181	0.00323	CcSEcCtD
Dapsone—Vomiting—Degarelix—prostate cancer	0.00018	0.00321	CcSEcCtD
Dapsone—Headache—Degarelix—prostate cancer	0.000178	0.00316	CcSEcCtD
Dapsone—Nausea—Estradiol valerate/Dienogest—prostate cancer	0.000177	0.00315	CcSEcCtD
Dapsone—Pharyngitis—Estradiol—prostate cancer	0.000177	0.00314	CcSEcCtD
Dapsone—Vertigo—Conjugated Estrogens—prostate cancer	0.000174	0.0031	CcSEcCtD
Dapsone—Sinusitis—Mitoxantrone—prostate cancer	0.000173	0.00308	CcSEcCtD
Dapsone—Cough—Goserelin—prostate cancer	0.000171	0.00303	CcSEcCtD
Dapsone—Vomiting—Cabazitaxel—prostate cancer	0.00017	0.00302	CcSEcCtD
Dapsone—Cough—Conjugated Estrogens—prostate cancer	0.000169	0.00301	CcSEcCtD
Dapsone—Nausea—Degarelix—prostate cancer	0.000169	0.003	CcSEcCtD
Dapsone—Headache—Cabazitaxel—prostate cancer	0.000168	0.00298	CcSEcCtD
Dapsone—Tinnitus—Estradiol—prostate cancer	0.000166	0.00295	CcSEcCtD
Dapsone—Pharyngitis—Mitoxantrone—prostate cancer	0.000165	0.00293	CcSEcCtD
Dapsone—Nausea—Cabazitaxel—prostate cancer	0.000159	0.00283	CcSEcCtD
Dapsone—Gastrointestinal pain—Ethinyl Estradiol—prostate cancer	0.000159	0.00282	CcSEcCtD
Dapsone—Tachycardia—Goserelin—prostate cancer	0.000156	0.00277	CcSEcCtD
Dapsone—Erythema—Estradiol—prostate cancer	0.000155	0.00276	CcSEcCtD
Dapsone—Tachycardia—Conjugated Estrogens—prostate cancer	0.000154	0.00274	CcSEcCtD
Dapsone—Abdominal pain—Ethinyl Estradiol—prostate cancer	0.000153	0.00273	CcSEcCtD
Dapsone—Body temperature increased—Ethinyl Estradiol—prostate cancer	0.000153	0.00273	CcSEcCtD
Dapsone—Neuropathy peripheral—Etoposide—prostate cancer	0.000151	0.00268	CcSEcCtD
Dapsone—Nasopharyngitis—Docetaxel—prostate cancer	0.000148	0.00264	CcSEcCtD
Dapsone—Skin exfoliation—Epirubicin—prostate cancer	0.000147	0.00262	CcSEcCtD
Dapsone—Sulfaphenazole—CYP2A6—prostate cancer	0.000146	0.0682	CrCbGaD
Dapsone—Vomiting—Bicalutamide—prostate cancer	0.000146	0.00259	CcSEcCtD
Dapsone—Erythema—Mitoxantrone—prostate cancer	0.000144	0.00257	CcSEcCtD
Dapsone—Insomnia—Goserelin—prostate cancer	0.000144	0.00257	CcSEcCtD
Dapsone—Headache—Bicalutamide—prostate cancer	0.000144	0.00256	CcSEcCtD
Dapsone—Nasopharyngitis—Capecitabine—prostate cancer	0.000144	0.00255	CcSEcCtD
Dapsone—Insomnia—Conjugated Estrogens—prostate cancer	0.000143	0.00254	CcSEcCtD
Dapsone—Muscular weakness—Capecitabine—prostate cancer	0.000142	0.00252	CcSEcCtD
Dapsone—PTGS1—lymph node—prostate cancer	0.000141	0.00437	CbGeAlD
Dapsone—Psychotic disorder—Prednisone—prostate cancer	0.00014	0.00248	CcSEcCtD
Dapsone—Vertigo—Estradiol—prostate cancer	0.000139	0.00248	CcSEcCtD
Dapsone—Influenza—Capecitabine—prostate cancer	0.000139	0.00247	CcSEcCtD
Dapsone—Nausea—Bicalutamide—prostate cancer	0.000136	0.00242	CcSEcCtD
Dapsone—Vision blurred—Mitoxantrone—prostate cancer	0.000136	0.00242	CcSEcCtD
Dapsone—Skin exfoliation—Doxorubicin—prostate cancer	0.000136	0.00242	CcSEcCtD
Dapsone—Cough—Estradiol—prostate cancer	0.000135	0.00241	CcSEcCtD
Dapsone—PTGS2—lymph node—prostate cancer	0.000135	0.00418	CbGeAlD
Dapsone—Gastrointestinal pain—Goserelin—prostate cancer	0.00013	0.00232	CcSEcCtD
Dapsone—Gastrointestinal pain—Conjugated Estrogens—prostate cancer	0.000129	0.0023	CcSEcCtD
Dapsone—Photosensitivity reaction—Capecitabine—prostate cancer	0.000127	0.00225	CcSEcCtD
Dapsone—Abdominal pain—Goserelin—prostate cancer	0.000126	0.00224	CcSEcCtD
Dapsone—Body temperature increased—Goserelin—prostate cancer	0.000126	0.00224	CcSEcCtD
Dapsone—Muscular weakness—Prednisone—prostate cancer	0.000126	0.00224	CcSEcCtD
Dapsone—Cough—Mitoxantrone—prostate cancer	0.000126	0.00224	CcSEcCtD
Dapsone—Neuropathy peripheral—Docetaxel—prostate cancer	0.000125	0.00223	CcSEcCtD
Dapsone—Abdominal pain—Conjugated Estrogens—prostate cancer	0.000125	0.00222	CcSEcCtD
Dapsone—Body temperature increased—Conjugated Estrogens—prostate cancer	0.000125	0.00222	CcSEcCtD
Dapsone—Tachycardia—Estradiol—prostate cancer	0.000123	0.0022	CcSEcCtD
Dapsone—Vomiting—Ethinyl Estradiol—prostate cancer	0.000123	0.00219	CcSEcCtD
Dapsone—Headache—Ethinyl Estradiol—prostate cancer	0.000121	0.00216	CcSEcCtD
Dapsone—Neuropathy peripheral—Capecitabine—prostate cancer	0.000121	0.00216	CcSEcCtD
Dapsone—Pancreatitis—Prednisone—prostate cancer	0.000121	0.00215	CcSEcCtD
Dapsone—Nausea—Ethinyl Estradiol—prostate cancer	0.000115	0.00205	CcSEcCtD
Dapsone—Tachycardia—Mitoxantrone—prostate cancer	0.000115	0.00205	CcSEcCtD
Dapsone—Insomnia—Estradiol—prostate cancer	0.000114	0.00204	CcSEcCtD
Dapsone—Pharyngitis—Docetaxel—prostate cancer	0.000114	0.00202	CcSEcCtD
Dapsone—Sulfadiazine—CYP2E1—prostate cancer	0.000113	0.053	CrCbGaD
Dapsone—Pharyngitis—Capecitabine—prostate cancer	0.00011	0.00196	CcSEcCtD
Dapsone—Neuropathy peripheral—Prednisone—prostate cancer	0.000108	0.00192	CcSEcCtD
Dapsone—Vertigo—Etoposide—prostate cancer	0.000108	0.00192	CcSEcCtD
Dapsone—Cough—Etoposide—prostate cancer	0.000105	0.00186	CcSEcCtD
Dapsone—Tinnitus—Capecitabine—prostate cancer	0.000104	0.00184	CcSEcCtD
Dapsone—Gastrointestinal pain—Estradiol—prostate cancer	0.000103	0.00184	CcSEcCtD
Dapsone—Vomiting—Goserelin—prostate cancer	0.000101	0.0018	CcSEcCtD
Dapsone—Vomiting—Conjugated Estrogens—prostate cancer	0.0001	0.00179	CcSEcCtD
Dapsone—Body temperature increased—Estradiol—prostate cancer	0.0001	0.00178	CcSEcCtD
Dapsone—Abdominal pain—Estradiol—prostate cancer	0.0001	0.00178	CcSEcCtD
Dapsone—Nasopharyngitis—Epirubicin—prostate cancer	0.0001	0.00178	CcSEcCtD
Dapsone—Headache—Goserelin—prostate cancer	0.0001	0.00178	CcSEcCtD
Dapsone—Erythema—Docetaxel—prostate cancer	9.98e-05	0.00178	CcSEcCtD
Dapsone—Headache—Conjugated Estrogens—prostate cancer	9.9e-05	0.00176	CcSEcCtD
Dapsone—Muscular weakness—Epirubicin—prostate cancer	9.86e-05	0.00175	CcSEcCtD
Dapsone—Erythema—Capecitabine—prostate cancer	9.67e-05	0.00172	CcSEcCtD
Dapsone—Influenza—Epirubicin—prostate cancer	9.66e-05	0.00172	CcSEcCtD
Dapsone—Gastrointestinal pain—Mitoxantrone—prostate cancer	9.64e-05	0.00171	CcSEcCtD
Dapsone—Tachycardia—Etoposide—prostate cancer	9.57e-05	0.0017	CcSEcCtD
Dapsone—Nausea—Goserelin—prostate cancer	9.48e-05	0.00169	CcSEcCtD
Dapsone—Pancreatitis—Epirubicin—prostate cancer	9.48e-05	0.00169	CcSEcCtD
Dapsone—Nausea—Conjugated Estrogens—prostate cancer	9.39e-05	0.00167	CcSEcCtD
Dapsone—Abdominal pain—Mitoxantrone—prostate cancer	9.32e-05	0.00166	CcSEcCtD
Dapsone—Body temperature increased—Mitoxantrone—prostate cancer	9.32e-05	0.00166	CcSEcCtD
Dapsone—Nasopharyngitis—Doxorubicin—prostate cancer	9.25e-05	0.00165	CcSEcCtD
Dapsone—Muscular weakness—Doxorubicin—prostate cancer	9.13e-05	0.00162	CcSEcCtD
Dapsone—Vision blurred—Capecitabine—prostate cancer	9.11e-05	0.00162	CcSEcCtD
Dapsone—Influenza—Doxorubicin—prostate cancer	8.94e-05	0.00159	CcSEcCtD
Dapsone—Photosensitivity reaction—Epirubicin—prostate cancer	8.82e-05	0.00157	CcSEcCtD
Dapsone—Pancreatitis—Doxorubicin—prostate cancer	8.77e-05	0.00156	CcSEcCtD
Dapsone—Cough—Docetaxel—prostate cancer	8.71e-05	0.00155	CcSEcCtD
Dapsone—Vertigo—Capecitabine—prostate cancer	8.68e-05	0.00154	CcSEcCtD
Dapsone—Erythema—Prednisone—prostate cancer	8.61e-05	0.00153	CcSEcCtD
Dapsone—Neuropathy peripheral—Epirubicin—prostate cancer	8.45e-05	0.0015	CcSEcCtD
Dapsone—Cough—Capecitabine—prostate cancer	8.43e-05	0.0015	CcSEcCtD
Dapsone—Photosensitivity reaction—Doxorubicin—prostate cancer	8.16e-05	0.00145	CcSEcCtD
Dapsone—Vision blurred—Prednisone—prostate cancer	8.11e-05	0.00144	CcSEcCtD
Dapsone—Sinusitis—Epirubicin—prostate cancer	8.08e-05	0.00144	CcSEcCtD
Dapsone—Vomiting—Estradiol—prostate cancer	8.04e-05	0.00143	CcSEcCtD
Dapsone—Gastrointestinal pain—Etoposide—prostate cancer	8.02e-05	0.00143	CcSEcCtD
Dapsone—Tachycardia—Docetaxel—prostate cancer	7.95e-05	0.00141	CcSEcCtD
Dapsone—Headache—Estradiol—prostate cancer	7.92e-05	0.00141	CcSEcCtD
Dapsone—Neuropathy peripheral—Doxorubicin—prostate cancer	7.82e-05	0.00139	CcSEcCtD
Dapsone—Abdominal pain—Etoposide—prostate cancer	7.75e-05	0.00138	CcSEcCtD
Dapsone—Body temperature increased—Etoposide—prostate cancer	7.75e-05	0.00138	CcSEcCtD
Dapsone—Vertigo—Prednisone—prostate cancer	7.74e-05	0.00138	CcSEcCtD
Dapsone—Sulfanilamide—CYP2E1—prostate cancer	7.71e-05	0.036	CrCbGaD
Dapsone—Tachycardia—Capecitabine—prostate cancer	7.7e-05	0.00137	CcSEcCtD
Dapsone—Pharyngitis—Epirubicin—prostate cancer	7.68e-05	0.00137	CcSEcCtD
Dapsone—Sulfanilamide—CYP2C19—prostate cancer	7.63e-05	0.0356	CrCbGaD
Dapsone—Nausea—Estradiol—prostate cancer	7.51e-05	0.00134	CcSEcCtD
Dapsone—Vomiting—Mitoxantrone—prostate cancer	7.49e-05	0.00133	CcSEcCtD
Dapsone—Sinusitis—Doxorubicin—prostate cancer	7.48e-05	0.00133	CcSEcCtD
Dapsone—Headache—Mitoxantrone—prostate cancer	7.38e-05	0.00131	CcSEcCtD
Dapsone—Insomnia—Docetaxel—prostate cancer	7.37e-05	0.00131	CcSEcCtD
Dapsone—Tinnitus—Epirubicin—prostate cancer	7.21e-05	0.00128	CcSEcCtD
Dapsone—Sulfadiazine—CYP3A4—prostate cancer	7.15e-05	0.0334	CrCbGaD
Dapsone—Insomnia—Capecitabine—prostate cancer	7.14e-05	0.00127	CcSEcCtD
Dapsone—Pharyngitis—Doxorubicin—prostate cancer	7.1e-05	0.00126	CcSEcCtD
Dapsone—Nausea—Mitoxantrone—prostate cancer	7e-05	0.00125	CcSEcCtD
Dapsone—Tachycardia—Prednisone—prostate cancer	6.86e-05	0.00122	CcSEcCtD
Dapsone—Erythema—Epirubicin—prostate cancer	6.73e-05	0.0012	CcSEcCtD
Dapsone—Tinnitus—Doxorubicin—prostate cancer	6.67e-05	0.00119	CcSEcCtD
Dapsone—Gastrointestinal pain—Docetaxel—prostate cancer	6.66e-05	0.00119	CcSEcCtD
Dapsone—Gastrointestinal pain—Capecitabine—prostate cancer	6.45e-05	0.00115	CcSEcCtD
Dapsone—Abdominal pain—Docetaxel—prostate cancer	6.44e-05	0.00115	CcSEcCtD
Dapsone—Body temperature increased—Docetaxel—prostate cancer	6.44e-05	0.00115	CcSEcCtD
Dapsone—Insomnia—Prednisone—prostate cancer	6.36e-05	0.00113	CcSEcCtD
Dapsone—Vision blurred—Epirubicin—prostate cancer	6.35e-05	0.00113	CcSEcCtD
Dapsone—Body temperature increased—Capecitabine—prostate cancer	6.24e-05	0.00111	CcSEcCtD
Dapsone—Abdominal pain—Capecitabine—prostate cancer	6.24e-05	0.00111	CcSEcCtD
Dapsone—Vomiting—Etoposide—prostate cancer	6.23e-05	0.00111	CcSEcCtD
Dapsone—Erythema—Doxorubicin—prostate cancer	6.23e-05	0.00111	CcSEcCtD
Dapsone—Headache—Etoposide—prostate cancer	6.14e-05	0.00109	CcSEcCtD
Dapsone—Vertigo—Epirubicin—prostate cancer	6.05e-05	0.00108	CcSEcCtD
Dapsone—Cough—Epirubicin—prostate cancer	5.88e-05	0.00105	CcSEcCtD
Dapsone—Vision blurred—Doxorubicin—prostate cancer	5.87e-05	0.00104	CcSEcCtD
Dapsone—Nausea—Etoposide—prostate cancer	5.82e-05	0.00104	CcSEcCtD
Dapsone—Gastrointestinal pain—Prednisone—prostate cancer	5.75e-05	0.00102	CcSEcCtD
Dapsone—Vertigo—Doxorubicin—prostate cancer	5.6e-05	0.000996	CcSEcCtD
Dapsone—Abdominal pain—Prednisone—prostate cancer	5.55e-05	0.000988	CcSEcCtD
Dapsone—Body temperature increased—Prednisone—prostate cancer	5.55e-05	0.000988	CcSEcCtD
Dapsone—Sulfamethoxazole—CYP3A4—prostate cancer	5.53e-05	0.0258	CrCbGaD
Dapsone—Cough—Doxorubicin—prostate cancer	5.44e-05	0.000967	CcSEcCtD
Dapsone—Tachycardia—Epirubicin—prostate cancer	5.36e-05	0.000954	CcSEcCtD
Dapsone—Vomiting—Docetaxel—prostate cancer	5.18e-05	0.000921	CcSEcCtD
Dapsone—Headache—Docetaxel—prostate cancer	5.1e-05	0.000908	CcSEcCtD
Dapsone—Vomiting—Capecitabine—prostate cancer	5.02e-05	0.000892	CcSEcCtD
Dapsone—Insomnia—Epirubicin—prostate cancer	4.97e-05	0.000884	CcSEcCtD
Dapsone—Tachycardia—Doxorubicin—prostate cancer	4.96e-05	0.000883	CcSEcCtD
Dapsone—Headache—Capecitabine—prostate cancer	4.94e-05	0.000879	CcSEcCtD
Dapsone—Sulfanilamide—CYP3A4—prostate cancer	4.85e-05	0.0227	CrCbGaD
Dapsone—Nausea—Docetaxel—prostate cancer	4.84e-05	0.000861	CcSEcCtD
Dapsone—Nausea—Capecitabine—prostate cancer	4.69e-05	0.000833	CcSEcCtD
Dapsone—Insomnia—Doxorubicin—prostate cancer	4.6e-05	0.000818	CcSEcCtD
Dapsone—Gastrointestinal pain—Epirubicin—prostate cancer	4.49e-05	0.000799	CcSEcCtD
Dapsone—Vomiting—Prednisone—prostate cancer	4.47e-05	0.000795	CcSEcCtD
Dapsone—Headache—Prednisone—prostate cancer	4.4e-05	0.000783	CcSEcCtD
Dapsone—Abdominal pain—Epirubicin—prostate cancer	4.34e-05	0.000773	CcSEcCtD
Dapsone—Body temperature increased—Epirubicin—prostate cancer	4.34e-05	0.000773	CcSEcCtD
Dapsone—Nausea—Prednisone—prostate cancer	4.17e-05	0.000742	CcSEcCtD
Dapsone—Gastrointestinal pain—Doxorubicin—prostate cancer	4.16e-05	0.00074	CcSEcCtD
Dapsone—Abdominal pain—Doxorubicin—prostate cancer	4.02e-05	0.000715	CcSEcCtD
Dapsone—Body temperature increased—Doxorubicin—prostate cancer	4.02e-05	0.000715	CcSEcCtD
Dapsone—Vomiting—Epirubicin—prostate cancer	3.49e-05	0.000622	CcSEcCtD
Dapsone—Headache—Epirubicin—prostate cancer	3.44e-05	0.000612	CcSEcCtD
Dapsone—Nausea—Epirubicin—prostate cancer	3.26e-05	0.000581	CcSEcCtD
Dapsone—Vomiting—Doxorubicin—prostate cancer	3.23e-05	0.000575	CcSEcCtD
Dapsone—Headache—Doxorubicin—prostate cancer	3.19e-05	0.000567	CcSEcCtD
Dapsone—Nausea—Doxorubicin—prostate cancer	3.02e-05	0.000537	CcSEcCtD
Dapsone—CYP2C8—Metabolism—RXRA—prostate cancer	1.56e-06	1.51e-05	CbGpPWpGaD
Dapsone—CYP3A5—Metabolism—LPL—prostate cancer	1.56e-06	1.51e-05	CbGpPWpGaD
Dapsone—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	1.55e-06	1.5e-05	CbGpPWpGaD
Dapsone—CYP2C18—Metabolism—EP300—prostate cancer	1.55e-06	1.5e-05	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—ABCG5—prostate cancer	1.55e-06	1.5e-05	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—SULT1A1—prostate cancer	1.55e-06	1.5e-05	CbGpPWpGaD
Dapsone—PTGS2—Disease—BAD—prostate cancer	1.55e-06	1.5e-05	CbGpPWpGaD
Dapsone—CYP3A7—Metabolism—INS—prostate cancer	1.54e-06	1.49e-05	CbGpPWpGaD
Dapsone—FMO3—Metabolism—AKT1—prostate cancer	1.54e-06	1.49e-05	CbGpPWpGaD
Dapsone—CYP2C19—Metabolism—CYP1B1—prostate cancer	1.54e-06	1.48e-05	CbGpPWpGaD
Dapsone—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	1.52e-06	1.47e-05	CbGpPWpGaD
Dapsone—CYP3A7—Metabolism—CREBBP—prostate cancer	1.51e-06	1.46e-05	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism—SLC5A5—prostate cancer	1.51e-06	1.46e-05	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—GSTA1—prostate cancer	1.51e-06	1.46e-05	CbGpPWpGaD
Dapsone—CYP2E1—Metabolism—CYP1A1—prostate cancer	1.51e-06	1.46e-05	CbGpPWpGaD
Dapsone—CYP3A5—Metabolism—CYP1A1—prostate cancer	1.51e-06	1.46e-05	CbGpPWpGaD
Dapsone—CYP2C8—Metabolism—COMT—prostate cancer	1.5e-06	1.45e-05	CbGpPWpGaD
Dapsone—PTGS2—Disease—APC—prostate cancer	1.5e-06	1.45e-05	CbGpPWpGaD
Dapsone—CYP2C8—Metabolism—GSTP1—prostate cancer	1.5e-06	1.45e-05	CbGpPWpGaD
Dapsone—PTGS1—Metabolism—INS—prostate cancer	1.5e-06	1.45e-05	CbGpPWpGaD
Dapsone—CYP2E1—Metabolism—ERCC2—prostate cancer	1.5e-06	1.45e-05	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—HSD3B2—prostate cancer	1.5e-06	1.44e-05	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—GSTO1—prostate cancer	1.5e-06	1.44e-05	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—NAT2—prostate cancer	1.5e-06	1.44e-05	CbGpPWpGaD
Dapsone—PTGS2—Metabolism—MTHFR—prostate cancer	1.49e-06	1.44e-05	CbGpPWpGaD
Dapsone—CYP3A5—Metabolism—ERCC2—prostate cancer	1.49e-06	1.44e-05	CbGpPWpGaD
Dapsone—CYP2C19—Metabolism—GGT1—prostate cancer	1.49e-06	1.44e-05	CbGpPWpGaD
Dapsone—PTGS2—Disease—EGF—prostate cancer	1.48e-06	1.43e-05	CbGpPWpGaD
Dapsone—PTGS2—Disease—IRS1—prostate cancer	1.48e-06	1.43e-05	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism—CYP2E1—prostate cancer	1.48e-06	1.43e-05	CbGpPWpGaD
Dapsone—CYP2C8—Metabolism—ITPR1—prostate cancer	1.47e-06	1.42e-05	CbGpPWpGaD
Dapsone—PTGS1—Metabolism—CREBBP—prostate cancer	1.47e-06	1.42e-05	CbGpPWpGaD
Dapsone—PTGS2—Metabolism—PPARA—prostate cancer	1.47e-06	1.42e-05	CbGpPWpGaD
Dapsone—CYP2C19—Metabolism—NCOA1—prostate cancer	1.47e-06	1.42e-05	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism—NQO1—prostate cancer	1.46e-06	1.41e-05	CbGpPWpGaD
Dapsone—CYP2C8—Metabolism of lipids and lipoproteins—EP300—prostate cancer	1.45e-06	1.4e-05	CbGpPWpGaD
Dapsone—CYP2C19—Metabolism—CYP19A1—prostate cancer	1.44e-06	1.4e-05	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism—TH—prostate cancer	1.44e-06	1.39e-05	CbGpPWpGaD
Dapsone—PTGS2—Disease—GSK3B—prostate cancer	1.44e-06	1.39e-05	CbGpPWpGaD
Dapsone—CYP3A7—Metabolism—PIK3CD—prostate cancer	1.43e-06	1.39e-05	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—PLCB2—prostate cancer	1.43e-06	1.39e-05	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—LRP2—prostate cancer	1.43e-06	1.39e-05	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—CYP2C18—prostate cancer	1.43e-06	1.39e-05	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	1.43e-06	1.38e-05	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism—CYP3A4—prostate cancer	1.42e-06	1.38e-05	CbGpPWpGaD
Dapsone—PTGS2—Disease—INS—prostate cancer	1.42e-06	1.37e-05	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	1.42e-06	1.37e-05	CbGpPWpGaD
Dapsone—CYP2E1—Metabolism—MTHFR—prostate cancer	1.41e-06	1.36e-05	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—P4HB—prostate cancer	1.41e-06	1.36e-05	CbGpPWpGaD
Dapsone—CYP3A5—Metabolism—MTHFR—prostate cancer	1.4e-06	1.36e-05	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism—CYP1B1—prostate cancer	1.4e-06	1.35e-05	CbGpPWpGaD
Dapsone—CYP2C19—Metabolism—RXRA—prostate cancer	1.39e-06	1.35e-05	CbGpPWpGaD
Dapsone—CYP2C8—Metabolism—TYMS—prostate cancer	1.39e-06	1.34e-05	CbGpPWpGaD
Dapsone—PTGS1—Metabolism—PIK3CD—prostate cancer	1.39e-06	1.34e-05	CbGpPWpGaD
Dapsone—PTGS2—Disease—CREBBP—prostate cancer	1.39e-06	1.34e-05	CbGpPWpGaD
Dapsone—CYP2E1—Metabolism—PPARA—prostate cancer	1.38e-06	1.33e-05	CbGpPWpGaD
Dapsone—PTGS2—Metabolism—CAV1—prostate cancer	1.38e-06	1.33e-05	CbGpPWpGaD
Dapsone—CYP3A5—Metabolism—PPARA—prostate cancer	1.38e-06	1.33e-05	CbGpPWpGaD
Dapsone—CYP2C8—Metabolism—GSTM1—prostate cancer	1.38e-06	1.33e-05	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—SLC22A1—prostate cancer	1.37e-06	1.32e-05	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism—GGT1—prostate cancer	1.36e-06	1.31e-05	CbGpPWpGaD
Dapsone—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	1.36e-06	1.31e-05	CbGpPWpGaD
Dapsone—CYP3A7—Metabolism—NOS3—prostate cancer	1.35e-06	1.31e-05	CbGpPWpGaD
Dapsone—CYP2C8—Metabolism—LPL—prostate cancer	1.35e-06	1.3e-05	CbGpPWpGaD
Dapsone—CYP2C19—Metabolism—COMT—prostate cancer	1.34e-06	1.3e-05	CbGpPWpGaD
Dapsone—CYP2C19—Metabolism—GSTP1—prostate cancer	1.34e-06	1.29e-05	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism—NCOA1—prostate cancer	1.34e-06	1.29e-05	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—SULT2A1—prostate cancer	1.33e-06	1.29e-05	CbGpPWpGaD
Dapsone—PTGS2—Disease—MAP2K1—prostate cancer	1.33e-06	1.28e-05	CbGpPWpGaD
Dapsone—PTGS2—Disease—PIK3CD—prostate cancer	1.32e-06	1.27e-05	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism—CYP19A1—prostate cancer	1.32e-06	1.27e-05	CbGpPWpGaD
Dapsone—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1.32e-06	1.27e-05	CbGpPWpGaD
Dapsone—CYP2C19—Metabolism—ITPR1—prostate cancer	1.31e-06	1.27e-05	CbGpPWpGaD
Dapsone—PTGS1—Metabolism—NOS3—prostate cancer	1.31e-06	1.27e-05	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—MED12—prostate cancer	1.31e-06	1.27e-05	CbGpPWpGaD
Dapsone—CYP2C8—Metabolism—CYP1A1—prostate cancer	1.3e-06	1.26e-05	CbGpPWpGaD
Dapsone—PTGS2—Disease—SERPINE1—prostate cancer	1.3e-06	1.26e-05	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—GNG5—prostate cancer	1.3e-06	1.26e-05	CbGpPWpGaD
Dapsone—CYP2E1—Metabolism—CAV1—prostate cancer	1.3e-06	1.25e-05	CbGpPWpGaD
Dapsone—CYP3A5—Metabolism—CAV1—prostate cancer	1.29e-06	1.25e-05	CbGpPWpGaD
Dapsone—CYP2C8—Metabolism—ERCC2—prostate cancer	1.29e-06	1.25e-05	CbGpPWpGaD
Dapsone—CYP2C19—Metabolism of lipids and lipoproteins—EP300—prostate cancer	1.29e-06	1.25e-05	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism—RXRA—prostate cancer	1.27e-06	1.23e-05	CbGpPWpGaD
Dapsone—PTGS2—Disease—FGF2—prostate cancer	1.26e-06	1.22e-05	CbGpPWpGaD
Dapsone—PTGS2—Metabolism—PIK3CG—prostate cancer	1.26e-06	1.21e-05	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—NCOA3—prostate cancer	1.25e-06	1.21e-05	CbGpPWpGaD
Dapsone—CYP3A7—Metabolism—PIK3CB—prostate cancer	1.25e-06	1.21e-05	CbGpPWpGaD
Dapsone—PTGS2—Disease—NOS3—prostate cancer	1.24e-06	1.2e-05	CbGpPWpGaD
Dapsone—CYP2C19—Metabolism—TYMS—prostate cancer	1.24e-06	1.2e-05	CbGpPWpGaD
Dapsone—CYP3A7—Metabolism—PTGS2—prostate cancer	1.24e-06	1.2e-05	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	1.24e-06	1.19e-05	CbGpPWpGaD
Dapsone—CYP2C19—Metabolism—GSTM1—prostate cancer	1.23e-06	1.19e-05	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism—COMT—prostate cancer	1.22e-06	1.18e-05	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism—GSTP1—prostate cancer	1.22e-06	1.18e-05	CbGpPWpGaD
Dapsone—CYP2C8—Metabolism—MTHFR—prostate cancer	1.22e-06	1.17e-05	CbGpPWpGaD
Dapsone—PTGS1—Metabolism—PIK3CB—prostate cancer	1.21e-06	1.17e-05	CbGpPWpGaD
Dapsone—PTGS2—Disease—JAK2—prostate cancer	1.21e-06	1.17e-05	CbGpPWpGaD
Dapsone—CYP2C19—Metabolism—LPL—prostate cancer	1.21e-06	1.16e-05	CbGpPWpGaD
Dapsone—PTGS1—Metabolism—PTGS2—prostate cancer	1.2e-06	1.16e-05	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism—ITPR1—prostate cancer	1.2e-06	1.16e-05	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—HPGDS—prostate cancer	1.2e-06	1.16e-05	CbGpPWpGaD
Dapsone—CYP2C8—Metabolism—PPARA—prostate cancer	1.19e-06	1.15e-05	CbGpPWpGaD
Dapsone—PTGS2—Metabolism—INS—prostate cancer	1.19e-06	1.15e-05	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—CYP2C19—prostate cancer	1.19e-06	1.15e-05	CbGpPWpGaD
Dapsone—CYP2E1—Metabolism—PIK3CG—prostate cancer	1.18e-06	1.14e-05	CbGpPWpGaD
Dapsone—PTGS2—Disease—MDM2—prostate cancer	1.18e-06	1.14e-05	CbGpPWpGaD
Dapsone—CYP3A5—Metabolism—PIK3CG—prostate cancer	1.18e-06	1.14e-05	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism of lipids and lipoproteins—EP300—prostate cancer	1.18e-06	1.14e-05	CbGpPWpGaD
Dapsone—CYP2C19—Metabolism—CYP1A1—prostate cancer	1.16e-06	1.12e-05	CbGpPWpGaD
Dapsone—PTGS2—Metabolism—CREBBP—prostate cancer	1.16e-06	1.12e-05	CbGpPWpGaD
Dapsone—PTGS2—Disease—ERBB2—prostate cancer	1.16e-06	1.12e-05	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—ACHE—prostate cancer	1.16e-06	1.12e-05	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—GSTT1—prostate cancer	1.16e-06	1.12e-05	CbGpPWpGaD
Dapsone—CYP2C19—Metabolism—ERCC2—prostate cancer	1.15e-06	1.12e-05	CbGpPWpGaD
Dapsone—PTGS2—Disease—PIK3CB—prostate cancer	1.15e-06	1.11e-05	CbGpPWpGaD
Dapsone—CYP2C18—Metabolism—PIK3CA—prostate cancer	1.15e-06	1.11e-05	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—CYP2A6—prostate cancer	1.15e-06	1.11e-05	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism—TYMS—prostate cancer	1.13e-06	1.09e-05	CbGpPWpGaD
Dapsone—CYP2C8—Metabolism—CAV1—prostate cancer	1.12e-06	1.08e-05	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism—GSTM1—prostate cancer	1.12e-06	1.08e-05	CbGpPWpGaD
Dapsone—CYP2E1—Metabolism—INS—prostate cancer	1.12e-06	1.08e-05	CbGpPWpGaD
Dapsone—CYP3A5—Metabolism—INS—prostate cancer	1.12e-06	1.08e-05	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—AKR1C3—prostate cancer	1.11e-06	1.08e-05	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—PRKACB—prostate cancer	1.11e-06	1.07e-05	CbGpPWpGaD
Dapsone—PTGS2—Metabolism—PIK3CD—prostate cancer	1.1e-06	1.07e-05	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism—LPL—prostate cancer	1.1e-06	1.06e-05	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—CYP17A1—prostate cancer	1.1e-06	1.06e-05	CbGpPWpGaD
Dapsone—CYP2E1—Metabolism—CREBBP—prostate cancer	1.1e-06	1.06e-05	CbGpPWpGaD
Dapsone—CYP3A5—Metabolism—CREBBP—prostate cancer	1.09e-06	1.06e-05	CbGpPWpGaD
Dapsone—CYP2C19—Metabolism—MTHFR—prostate cancer	1.09e-06	1.05e-05	CbGpPWpGaD
Dapsone—CYP3A7—Metabolism—PTEN—prostate cancer	1.08e-06	1.04e-05	CbGpPWpGaD
Dapsone—PTGS2—Disease—CDKN1B—prostate cancer	1.08e-06	1.04e-05	CbGpPWpGaD
Dapsone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1.07e-06	1.04e-05	CbGpPWpGaD
Dapsone—CYP2C19—Metabolism—PPARA—prostate cancer	1.06e-06	1.03e-05	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism—CYP1A1—prostate cancer	1.06e-06	1.03e-05	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism—ERCC2—prostate cancer	1.05e-06	1.02e-05	CbGpPWpGaD
Dapsone—PTGS1—Metabolism—PTEN—prostate cancer	1.05e-06	1.01e-05	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—NCOA2—prostate cancer	1.05e-06	1.01e-05	CbGpPWpGaD
Dapsone—PTGS2—Metabolism—NOS3—prostate cancer	1.04e-06	1.01e-05	CbGpPWpGaD
Dapsone—CYP2E1—Metabolism—PIK3CD—prostate cancer	1.04e-06	1e-05	CbGpPWpGaD
Dapsone—CYP3A5—Metabolism—PIK3CD—prostate cancer	1.04e-06	1e-05	CbGpPWpGaD
Dapsone—CYP3A7—Metabolism—EP300—prostate cancer	1.03e-06	9.96e-06	CbGpPWpGaD
Dapsone—CYP2C8—Metabolism—PIK3CG—prostate cancer	1.02e-06	9.87e-06	CbGpPWpGaD
Dapsone—PTGS2—Disease—CTNNB1—prostate cancer	1.02e-06	9.84e-06	CbGpPWpGaD
Dapsone—CYP2C19—Metabolism—CAV1—prostate cancer	1e-06	9.67e-06	CbGpPWpGaD
Dapsone—PTGS1—Metabolism—EP300—prostate cancer	9.99e-07	9.65e-06	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—SLC5A5—prostate cancer	9.98e-07	9.64e-06	CbGpPWpGaD
Dapsone—PTGS2—Disease—CDKN1A—prostate cancer	9.95e-07	9.61e-06	CbGpPWpGaD
Dapsone—PTGS2—Disease—PTEN—prostate cancer	9.93e-07	9.59e-06	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism—MTHFR—prostate cancer	9.9e-07	9.56e-06	CbGpPWpGaD
Dapsone—CYP2E1—Metabolism—NOS3—prostate cancer	9.81e-07	9.48e-06	CbGpPWpGaD
Dapsone—CYP3A5—Metabolism—NOS3—prostate cancer	9.79e-07	9.46e-06	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—CYP2E1—prostate cancer	9.74e-07	9.42e-06	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism—PPARA—prostate cancer	9.71e-07	9.38e-06	CbGpPWpGaD
Dapsone—CYP2C8—Metabolism—INS—prostate cancer	9.67e-07	9.34e-06	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—NQO1—prostate cancer	9.63e-07	9.31e-06	CbGpPWpGaD
Dapsone—PTGS2—Metabolism—PIK3CB—prostate cancer	9.62e-07	9.3e-06	CbGpPWpGaD
Dapsone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	9.56e-07	9.24e-06	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—TH—prostate cancer	9.5e-07	9.18e-06	CbGpPWpGaD
Dapsone—CYP2C8—Metabolism—CREBBP—prostate cancer	9.47e-07	9.15e-06	CbGpPWpGaD
Dapsone—PTGS2—Disease—EP300—prostate cancer	9.47e-07	9.15e-06	CbGpPWpGaD
Dapsone—CYP2C18—Metabolism—AKT1—prostate cancer	9.37e-07	9.05e-06	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—CYP1B1—prostate cancer	9.24e-07	8.93e-06	CbGpPWpGaD
Dapsone—PTGS2—Disease—SRC—prostate cancer	9.21e-07	8.9e-06	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism—CAV1—prostate cancer	9.13e-07	8.82e-06	CbGpPWpGaD
Dapsone—CYP2C19—Metabolism—PIK3CG—prostate cancer	9.12e-07	8.81e-06	CbGpPWpGaD
Dapsone—CYP2E1—Metabolism—PIK3CB—prostate cancer	9.06e-07	8.75e-06	CbGpPWpGaD
Dapsone—CYP3A5—Metabolism—PIK3CB—prostate cancer	9.04e-07	8.73e-06	CbGpPWpGaD
Dapsone—CYP2C8—Metabolism—PIK3CD—prostate cancer	8.98e-07	8.68e-06	CbGpPWpGaD
Dapsone—CYP2E1—Metabolism—PTGS2—prostate cancer	8.97e-07	8.67e-06	CbGpPWpGaD
Dapsone—CYP3A5—Metabolism—PTGS2—prostate cancer	8.95e-07	8.65e-06	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—GGT1—prostate cancer	8.95e-07	8.64e-06	CbGpPWpGaD
Dapsone—PTGS2—Disease—STAT3—prostate cancer	8.88e-07	8.58e-06	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—NCOA1—prostate cancer	8.81e-07	8.52e-06	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	8.72e-07	8.43e-06	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—CYP19A1—prostate cancer	8.68e-07	8.39e-06	CbGpPWpGaD
Dapsone—CYP2C19—Metabolism—INS—prostate cancer	8.63e-07	8.34e-06	CbGpPWpGaD
Dapsone—CYP2C8—Metabolism—NOS3—prostate cancer	8.48e-07	8.19e-06	CbGpPWpGaD
Dapsone—CYP2C19—Metabolism—CREBBP—prostate cancer	8.45e-07	8.17e-06	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—RXRA—prostate cancer	8.38e-07	8.1e-06	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism—PIK3CG—prostate cancer	8.31e-07	8.03e-06	CbGpPWpGaD
Dapsone—PTGS2—Metabolism—PTEN—prostate cancer	8.31e-07	8.03e-06	CbGpPWpGaD
Dapsone—PTGS2—Disease—MYC—prostate cancer	8.25e-07	7.97e-06	CbGpPWpGaD
Dapsone—PTGS2—Disease—TGFB1—prostate cancer	8.23e-07	7.95e-06	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—COMT—prostate cancer	8.07e-07	7.8e-06	CbGpPWpGaD
Dapsone—PTGS2—Disease—EGFR—prostate cancer	8.07e-07	7.8e-06	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—GSTP1—prostate cancer	8.04e-07	7.77e-06	CbGpPWpGaD
Dapsone—CYP2C19—Metabolism—PIK3CD—prostate cancer	8.02e-07	7.75e-06	CbGpPWpGaD
Dapsone—PTGS2—Metabolism—EP300—prostate cancer	7.93e-07	7.66e-06	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—ITPR1—prostate cancer	7.91e-07	7.64e-06	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism—INS—prostate cancer	7.87e-07	7.61e-06	CbGpPWpGaD
Dapsone—CYP2C8—Metabolism—PIK3CB—prostate cancer	7.83e-07	7.56e-06	CbGpPWpGaD
Dapsone—CYP2E1—Metabolism—PTEN—prostate cancer	7.83e-07	7.56e-06	CbGpPWpGaD
Dapsone—CYP3A5—Metabolism—PTEN—prostate cancer	7.81e-07	7.55e-06	CbGpPWpGaD
Dapsone—CYP2C8—Metabolism—PTGS2—prostate cancer	7.76e-07	7.49e-06	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism—CREBBP—prostate cancer	7.71e-07	7.45e-06	CbGpPWpGaD
Dapsone—PTGS2—Disease—KRAS—prostate cancer	7.62e-07	7.37e-06	CbGpPWpGaD
Dapsone—CYP3A7—Metabolism—PIK3CA—prostate cancer	7.62e-07	7.36e-06	CbGpPWpGaD
Dapsone—CYP2C19—Metabolism—NOS3—prostate cancer	7.57e-07	7.31e-06	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—TYMS—prostate cancer	7.47e-07	7.22e-06	CbGpPWpGaD
Dapsone—CYP2E1—Metabolism—EP300—prostate cancer	7.46e-07	7.21e-06	CbGpPWpGaD
Dapsone—CYP3A5—Metabolism—EP300—prostate cancer	7.45e-07	7.2e-06	CbGpPWpGaD
Dapsone—PTGS1—Metabolism—PIK3CA—prostate cancer	7.39e-07	7.14e-06	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—GSTM1—prostate cancer	7.38e-07	7.14e-06	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism—PIK3CD—prostate cancer	7.31e-07	7.06e-06	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—LPL—prostate cancer	7.25e-07	7e-06	CbGpPWpGaD
Dapsone—PTGS2—Disease—PIK3CA—prostate cancer	7e-07	6.77e-06	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—CYP1A1—prostate cancer	7e-07	6.76e-06	CbGpPWpGaD
Dapsone—CYP2C19—Metabolism—PIK3CB—prostate cancer	6.99e-07	6.75e-06	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—ERCC2—prostate cancer	6.94e-07	6.71e-06	CbGpPWpGaD
Dapsone—CYP2C19—Metabolism—PTGS2—prostate cancer	6.92e-07	6.69e-06	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism—NOS3—prostate cancer	6.9e-07	6.67e-06	CbGpPWpGaD
Dapsone—CYP2C8—Metabolism—PTEN—prostate cancer	6.76e-07	6.54e-06	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—MTHFR—prostate cancer	6.53e-07	6.31e-06	CbGpPWpGaD
Dapsone—CYP2C8—Metabolism—EP300—prostate cancer	6.45e-07	6.23e-06	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—PPARA—prostate cancer	6.4e-07	6.19e-06	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism—PIK3CB—prostate cancer	6.37e-07	6.16e-06	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism—PTGS2—prostate cancer	6.31e-07	6.1e-06	CbGpPWpGaD
Dapsone—CYP3A7—Metabolism—AKT1—prostate cancer	6.23e-07	6.02e-06	CbGpPWpGaD
Dapsone—PTGS2—Disease—IL6—prostate cancer	6.2e-07	5.99e-06	CbGpPWpGaD
Dapsone—CYP2C19—Metabolism—PTEN—prostate cancer	6.04e-07	5.83e-06	CbGpPWpGaD
Dapsone—PTGS1—Metabolism—AKT1—prostate cancer	6.03e-07	5.83e-06	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—CAV1—prostate cancer	6.02e-07	5.82e-06	CbGpPWpGaD
Dapsone—PTGS2—Metabolism—PIK3CA—prostate cancer	5.86e-07	5.67e-06	CbGpPWpGaD
Dapsone—CYP2C19—Metabolism—EP300—prostate cancer	5.76e-07	5.56e-06	CbGpPWpGaD
Dapsone—PTGS2—Disease—AKT1—prostate cancer	5.72e-07	5.53e-06	CbGpPWpGaD
Dapsone—CYP2E1—Metabolism—PIK3CA—prostate cancer	5.52e-07	5.33e-06	CbGpPWpGaD
Dapsone—CYP3A5—Metabolism—PIK3CA—prostate cancer	5.51e-07	5.32e-06	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism—PTEN—prostate cancer	5.5e-07	5.32e-06	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—PIK3CG—prostate cancer	5.48e-07	5.3e-06	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism—EP300—prostate cancer	5.25e-07	5.07e-06	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—INS—prostate cancer	5.19e-07	5.02e-06	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—CREBBP—prostate cancer	5.08e-07	4.91e-06	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—PIK3CD—prostate cancer	4.82e-07	4.66e-06	CbGpPWpGaD
Dapsone—PTGS2—Metabolism—AKT1—prostate cancer	4.79e-07	4.63e-06	CbGpPWpGaD
Dapsone—CYP2C8—Metabolism—PIK3CA—prostate cancer	4.77e-07	4.61e-06	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—NOS3—prostate cancer	4.55e-07	4.4e-06	CbGpPWpGaD
Dapsone—CYP2E1—Metabolism—AKT1—prostate cancer	4.51e-07	4.36e-06	CbGpPWpGaD
Dapsone—CYP3A5—Metabolism—AKT1—prostate cancer	4.5e-07	4.35e-06	CbGpPWpGaD
Dapsone—CYP2C19—Metabolism—PIK3CA—prostate cancer	4.26e-07	4.12e-06	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—PIK3CB—prostate cancer	4.2e-07	4.06e-06	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—PTGS2—prostate cancer	4.16e-07	4.02e-06	CbGpPWpGaD
Dapsone—CYP2C8—Metabolism—AKT1—prostate cancer	3.9e-07	3.77e-06	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism—PIK3CA—prostate cancer	3.88e-07	3.75e-06	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—PTEN—prostate cancer	3.63e-07	3.51e-06	CbGpPWpGaD
Dapsone—CYP2C19—Metabolism—AKT1—prostate cancer	3.48e-07	3.36e-06	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—EP300—prostate cancer	3.46e-07	3.35e-06	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism—AKT1—prostate cancer	3.17e-07	3.07e-06	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—PIK3CA—prostate cancer	2.56e-07	2.48e-06	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—AKT1—prostate cancer	2.09e-07	2.02e-06	CbGpPWpGaD
